Angina Market Analysis, Upcoming Trends, Emerging Growth, Key Players Segments and Forecast to 2023
Angina Market is
expected to grow at an approximate CAGR of 5.1% during the forecast period
The rising prevalence of angina and coronary heart diseases,
growing healthcare expenditure, and increasing geriatric and obese population
are expected to drive the global angina market, during the forecast period.
However, low per capita healthcare expenditure and high cost for therapeutic
procedures such as coronary bypass surgery restraints the market growth.
The Market Key Players are:
·
Anthera (U.S.),
·
Taxus Cardium (U.S.),
·
Astellas Pharma (Japan),
·
Sanofi (France),
·
Bayer AG (Germany),
·
Merck & Co., Inc. (U.S.),
·
Torrent Pharmaceuticals Limited (India),
·
Huya Bioscience International (U.S.),
·
Viromed Co. Ltd. (South Korea),
·
Baxter (U.S.),
Segmentation
The global angina market is segmented on the basis of type,
diagnosis, treatment, and end-user.
·
On the basis of type, the market is segmented
into angina pectoris, unstable angina, prinzmetal angina, and others.
·
On the basis of diagnosis, the market is
categorized into imaging, blood test, stress test, and others. The imaging
segment is sub-segmented into electrocardiogram, chest X-ray, cardiac
computerized tomography scan, cardiac MRI, and others. The blood test segment
is sub-segmented into cholesterol test, low-density lipoprotein test,
triglycerides test, and others.
·
On the basis of treatment, the market is
segmented into lifestyle changes, medications, angioplasty and stenting,
coronary bypass surgery, and others. The medication segment is sub-segmented
into aspirin, clot-preventing drugs, statins, ranolazine, and others. The
clot-preventing drugs segment is further segmented into clopidogrel, prasugrel,
and others.
·
On the basis of end-user, the market is
segmented into hospitals and clinics, diagnostic centers, academic institutes,
and others
Global Angina Market Research Report, by Type (Angina
Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications,
Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic
Centers, Academic Institutes)–Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/angina-market-5748
Regional Analysis
America dominates the global angina market. This can be
attributed to the presence of a well-developed healthcare sector and a huge
patient population for coronary heart diseases. Additionally, key players such
as Merck & Co., Inc. and Baxter within the region fuel the market growth.
Europe stands second in the global market for angina. Availability of funds for
research, growing number of obese and patient population, and the presence of
developed economies such as France, Italy, and Germany within the region are
the major drivers for the market growth within the region.
Asia Pacific is estimated to be the fastest growing region,
owing to the presence of developing economies such as India and China and a
developing healthcare sector. Moreover, factors such as rising healthcare
expenditure and favorable government policies are expected to boost the market
growth during the forecast period. The Middle East and Africa hold the least
share in the market. This can be attributed to the presence of poor economies,
stringent government policies, and low per capita healthcare expenditure,
especially within the African region. A majority of the market of the region is
held by the Middle East.
About Us:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Comments
Post a Comment